statepi home
Homepage MACS Homepage WIHS Homepage CKID Homepage
Liver Cancer
Software



Biomarkers Homepage
Oltipraz Homepage
Publications


                      Liver Cancer, HBV and Aflatoxin

Biomarkers
This study, started in 1993, is composed of 3 projects on molecular biomarkers for environmental carcinogens.


OCT
The Oltipraz Chemoprevention Trial is a Phase II randomized clinical trial designed to evaluate weekly and daily administrations of oltipraz for reducing urinary and/or serum aflatoxin biomarkers compared to placebo.


Funding provided by the National Institute of Environmental Health Sciences
and the National Cancer Institute.

This page was last updated October 2001.